Tokyo, Japan

Tadaomi Takenawa


Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2002-2006

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Tadaomi Takenawa: Innovator in Biochemical Research

Introduction

Tadaomi Takenawa is a prominent inventor based in Tokyo, Japan. He has made significant contributions to the field of biochemistry, particularly in the area of lysophosphatidic acid phosphatase research. With a total of 2 patents, his work has implications for both medical diagnostics and treatment.

Latest Patents

One of Tadaomi Takenawa's latest patents focuses on recombinant lysophosphatidic acid phosphatase. The objective of this invention is to provide a recombinant LPA phosphatase capable of specifically hydrolyzing LPA. This is useful for elucidating the metabolism pathway of LPA and for diagnosing and treating various diseases associated with LPA. The invention includes a method for simply and inexpensively determining LPA associated with various diseases, as well as a kit for determination suitable for this method. The successful purification of LPA phosphatase using bovine brain as raw material and the cloning of the human LPA phosphatase gene are notable achievements of this patent.

Career Highlights

Tadaomi Takenawa is currently employed at Azwell Inc., where he continues to advance his research in biochemistry. His work has garnered attention for its potential applications in medical science and diagnostics.

Collaborations

Some of his notable coworkers include Masami Hiroyama and Tatsuya Kishimoto. Their collaborative efforts contribute to the innovative research environment at Azwell Inc.

Conclusion

Tadaomi Takenawa's contributions to the field of biochemistry, particularly through his patents on lysophosphatidic acid phosphatase, highlight his role as an influential inventor. His work not only furthers scientific understanding but also has practical applications in healthcare.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…